| |
| |
|
| Insider
Information: |
Harwin Peter Evan |
| Relationship: |
|
| City: |
Solana Beach, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
9,743,993 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$115,093,552 |
|
|
| Total
Shares |
9,743,993 |
|
|
| Total
Value |
$115,093,552 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeglea Biotherapeutics, Inc. |
AGLE |
|
|
0 |
2024-04-25 |
4,830,177 |
Premium* |
|
|
Apogee Therapeutics, Inc. |
APGE |
Director |
2023-07-13 |
0 |
2024-03-28 |
2,150,979 |
Premium* |
|
|
Dianthus Therapeutics Ord Shs |
DNTH |
|
2023-09-12 |
0 |
2024-01-22 |
2,762,837 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGLE |
Aeglea Biotherapeutics, I... |
|
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,639,680 |
4,018,101 |
0 |
- |
|
| APGE |
Apogee Therapeutics, Inc. |
Director |
– • – |
2024-03-28 |
4 |
A |
$0.00 |
$0 |
I/I |
55,913 |
2,048,647 |
0 |
- |
|
| APGE |
Apogee Therapeutics, Inc. |
Director |
– • – |
2024-03-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(55,913) |
0 |
0 |
- |
|
| APGE |
Apogee Therapeutics, Inc. |
Director |
– • – |
2024-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
102,332 |
51,166 |
0 |
- |
|
| APGE |
Apogee Therapeutics, Inc. |
Director |
– • – |
2024-01-29 |
4 |
AS |
$0.00 |
$0 |
I/I |
(892,529) |
0 |
0 |
% |
|
| DNTH |
Dianthus Therapeutics Ord... |
|
– • • |
2024-01-22 |
4 |
A |
$12.00 |
$10,012,008 |
I/I |
834,334 |
2,762,837 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
|
– • • |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
812,076 |
406,038 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
|
– • • |
2023-12-29 |
4 |
AS |
$0.00 |
$0 |
I/I |
(3,435,480) |
0 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
|
– • • |
2023-11-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,435,480 |
3,435,480 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Director |
– • • |
2023-09-29 |
4 |
B |
$13.63 |
$336,252 |
I/I |
24,670 |
1,928,503 |
2.25 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Director |
– • • |
2023-09-19 |
4 |
B |
$13.20 |
$396,000 |
I/I |
30,000 |
1,873,833 |
2.25 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
|
– • • |
2023-09-13 |
4 |
B |
$11.76 |
$110,156 |
I/I |
9,367 |
1,843,833 |
0.01 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
|
– • • |
2023-09-12 |
4 |
B |
$10.85 |
$161,524 |
I/I |
14,887 |
1,834,466 |
0.01 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
|
– • • |
2023-09-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,819,579 |
|
- |
|
| APGE |
Apogee Therapeutics, Inc. |
Director |
– • – |
2023-07-13 |
4 |
B |
$17.00 |
$49,999,992 |
I/I |
2,941,176 |
892,529 |
2.1 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
|
– • • |
2023-06-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,460,540 |
|
% |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
